<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 10Q 9/30/00 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FORM 10Q </LEGEND> <CIK> 0000874384 <NAME> CAMBRIDGE NEUROSCIENCE INC. <MULTIPLIER> 1 <CURRENCY> U.S. $ <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-2000 <PERIOD-START> JUL-01-2000 <PERIOD-END> SEP-30-2000 <EXCHANGE-RATE> 1 <CASH> 1,340 <SECURITIES> 5,994 <RECEIVABLES> 8 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 7,708 <PP&E> 481 <DEPRECIATION> 0 <TOTAL-ASSETS> 8,189 <CURRENT-LIABILITIES> 823 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 18 <OTHER-SE> 7,348 <TOTAL-LIABILITY-AND-EQUITY> 8,189 <SALES> 0 <TOTAL-REVENUES> 1,012 <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> 4,073 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (2,661) <INCOME-TAX> 0 <INCOME-CONTINUING> (2,661) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (2,661) <EPS-BASIC> (0.15) <EPS-DILUTED> (0.15)